Description

5H-Pyrazino[2,3-D]Azepin-2-Amine,7-Ethyl-6,7,8,9-Tetrahydro-6-Methyl-(9Ci) is a high-purity, advanced pharmaceutical intermediate belonging to a class of fused heterocyclic compounds. This compound matters for its critical role as a sophisticated building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. Pharmaceutical R&D teams and fine chemical manufacturers need this precise chemical entity to develop next-generation drug candidates targeting central nervous system disorders, oncology, and other specialized medical fields.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the research and development of novel drug molecules.
• Active Pharmaceutical Ingredient (API) Synthesis: Used in the complex multi-step synthesis of potential APIs, especially for neurological and oncological targets.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Biochemical Tool Compound: Employed in pharmacological assays to study specific enzyme or receptor interactions.
• Contract Manufacturing & Development (CDMO): Supplied to CDMOs for cGMP-scale production of clinical trial materials.
• Academic Research: Used in university and institutional labs for advanced organic synthesis and heterocyclic chemistry studies.

Basic Information

Product Name	5H-Pyrazino[2,3-D]Azepin-2-Amine,7-Ethyl-6,7,8,9-Tetrahydro-6-Methyl-(9Ci)
CAS No.	768313-60-6
Molecular Formula	C11H18N4
Molecular Weight	206.29 g/mol
Synonyms	7-Ethyl-6,7,8,9-tetrahydro-6-methyl-5H-pyrazino[2,3-d]azepin-2-amine; 5H-Pyrazino[2,3-d]azepin-2-amine, 7-ethyl-6,7,8,9-tetrahydro-6-methyl-; 768313-60-6; 7-Ethyl-6-methyl-6,7,8,9-tetrahydro-5H-pyrazino[2,3-d]azepin-2-amine; SCHEMBL21806227; ZINC000253909991; AKOS040759232; DTXSID60672969
EINECS	Contact for details

Quality Control

Our 5H-Pyrazino[2,3-D]Azepin-2-Amine,7-Ethyl-6,7,8,9-Tetrahydro-6-Methyl-(9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for pharmaceutical R&D and development. Certificates of Analysis (COA) with detailed chromatographic data are available for every lot, providing full traceability and compliance support for your regulatory filings.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). This material is moisture-sensitive (hygroscopic); keep the original container tightly sealed under an inert atmosphere to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.